BioXcel Therapeutics, Inc.
BTAI
$1.88
$0.02991.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -54.23% | -55.11% | -55.88% | -55.21% | -66.33% |
| Total Receivables | 84.51% | -99.59% | 88.40% | 33.57% | -71.37% |
| Inventory | -65.90% | -24.43% | 39.22% | 24.95% | 0.30% |
| Prepaid Expenses | 90.15% | 16.25% | -24.96% | -53.33% | -9.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -30.70% | -35.61% | -64.56% | -62.92% | -45.93% |
| Total Current Assets | -48.17% | -51.60% | -53.57% | -54.35% | -64.44% |
|
|
|||||
| Total Current Assets | -48.17% | -51.60% | -53.57% | -54.35% | -64.44% |
| Net Property, Plant & Equipment | -41.78% | -37.62% | -34.25% | -30.94% | -28.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -90.59% | -90.59% |
| Total Assets | -47.98% | -51.33% | -53.29% | -54.29% | -64.20% |
|
|
|||||
| Total Accounts Payable | 17.11% | 39.55% | 18.33% | 122.42% | 33.50% |
| Total Accrued Expenses | -56.06% | -69.03% | -41.19% | -32.19% | -40.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 8.55% | 8.73% | 8.62% | -- |
| Total Finance Division Other Current Liabilities | -80.30% | 135.51% | -33.21% | -57.95% | -4.94% |
| Total Other Current Liabilities | -80.30% | 135.51% | -33.21% | -57.95% | -4.94% |
| Total Current Liabilities | -18.46% | -35.15% | -21.46% | 9.46% | -17.12% |
|
|
|||||
| Total Current Liabilities | -18.46% | -35.15% | -21.46% | 9.46% | -17.12% |
| Long-Term Debt | 1.90% | 5.40% | 6.36% | 6.91% | 8.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -85.23% | -69.57% | -58.51% | -50.21% | -44.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 248.19% | 115.44% | 353.41% | 724.48% | -18.69% |
| Total Liabilities | 0.94% | -4.63% | 4.10% | 21.71% | 0.88% |
|
|
|||||
| Common Stock & APIC | 4.31% | 4.92% | 5.28% | 5.35% | 9.37% |
| Retained Earnings | -10.09% | -12.49% | -20.82% | -32.96% | -43.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -64.76% | -110.88% | -1,367.07% | -236.52% | -173.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -64.76% | -110.88% | -1,367.07% | -236.52% | -173.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -64.76% | -110.88% | -1,367.07% | -236.52% | -173.60% |
|
|
|||||